Ethypharm in the news
Essential drugs for hospitals
Tamtam found 20 recent articles about Ethypharm.
- Public Health Campaign Raises Awareness of Drug Supply Contamination
Ethypharm's new public health campaign addresses the 400% surge in nitazene-related deaths by warning of highly potent illicit drug contamination across the UK.
- Ethypharm announces the appointment of Éric CHEVALIER as Group Human Resources Director
Éric Chevalier joined Ethypharm as Group Human Resources Director on October 1, 2024, to manage global talent and organizational growth.
- Ethypharm annonce la nomination d'Éric Chevalier en tant que Directeur des Ressources Humaines Groupe
Ethypharm has appointed industry veteran Éric Chevalier as Group Human Resources Director to lead talent development and organizational growth.
- Ethypharm Expands Portfolio with Acquisition of Mesalazine Suppository by Chinese Affiliate
Ethypharm's Chinese affiliate acquired a Mesalazine suppository from Jiangsu Anbison Pharmaceutical to expand its portfolio and meet patient demand in China.
- Ethypharm s’injecte un build-up en Espagne
Ethypharm completes its first build-up acquisition in Spain since its 725 million LBO with PAI five years ago.
- Ethypharm lance la première thérapie numérique dans la dépression sans attendre son éventuel remboursement
Ethypharm is launching a clinically validated digital therapy platform for depression in France following its acquisition of Deprexis.
- Kenya is granted special Caffeine Citrate pricing after Clinton Health Access Initiative led negotiations with Ethypharm
A pricing agreement with Ethypharm reduces the cost of Caffeine Citrate by 70% to improve survival rates for premature infants in Kenya.
- Ethypharm annonce la nomination de Xavier LASSERRE en tant que nouveau Directeur Commercial
Xavier Lasserre has been appointed as the new Chief Commercial Officer of Ethypharm to drive global market expansion and commercial strategy.
- Aurora selected for extended trial
Aurora and Ethypharm have secured an extension to exclusively supply medical cannabis for France's ongoing national therapeutic trial through March 2024.
- Aurora and Ethypharm Reaffirm their Commitment to Promote Access to Medical Cannabis for French Patients
Aurora Europe and Ethypharm have been re-selected as exclusive suppliers of dried medical cannabis flower for the extended French trial until March 2024, continuing their partnership to improve access to medical cannabis.
- Ethypharm lance la première thérapie numérique dans la dépression sans attendre son éventuel remboursement
Ethypharm has launched Deprexis, a clinically-tested digital medical device for treating depression via online cognitive behavioral therapy modules.
- Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK
Ethypharm has appointed industry veteran Bruno Ultra BARCELOS as the Managing Director for its UK operations, which account for nearly a third of its revenue.
- Bruno Ultra BARCELOS is appointed Managing Director of Ethypharm UK
Bruno Ultra Barcelos was appointed Managing Director of Ethypharm UK, bringing 30 years of pharmaceutical experience from major international groups.
- Ethypharm, à Châteauneuf-en-Thymerais, confirme son engagement au service de la sous-traitance du secteur du médicament
Ethypharm is scaling up its pharmaceutical subcontracting activities and industrial capacity in France while investing in sustainable energy infrastructure.
- Denis DELVAL is appointed President of the Ethypharm Group
Denis DELVAL has been appointed as the new President of Ethypharm Group, a European pharmaceutical company specializing in CNS and hospital injectables.
- Clever Leaves Holdings Begins Sales of Cannabis Extracts in Germany Through Ethypharm Partnership
Clever Leaves is launching medical cannabis extracts in Germany through a commercial partnership and distribution agreement with Ethypharm.
- Financiere Verdi I S.A.S. -- Moody's downgrades Ethypharm's rating to B3, outlook stable
Moody's downgraded Ethypharm's rating to B3 with a stable outlook due to high leverage, delayed deleveraging from the Altan acquisition, and weaker 2021 performance, despite expected improvements from the acquisition.
- Aurora Delivers Medical Cannabis to France Pilot Program
Aurora Cannabis and Ethypharm have initiated a two-year medical cannabis pilot program in France, supplying dried cannabis flower to 3,000 patients.
- Ethypharm builds up European presence with Altan acquisition
Ethypharm is acquiring Spanish firm Altan Pharma to strengthen its European presence.
- Malin's Altan Pharma to be bought by Ethypharm
Ethypharm acquired Altan Pharma, a specialty pharmaceutical company, from Malin Corporation, which is expected to yield approximately –68m for Malin.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Ethypharm?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies